Jun 11 |
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying
|
May 28 |
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
|
May 23 |
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
|
May 20 |
Phio Pharmaceuticals files for $100M mixed shelf
|
May 17 |
Phio Pharmaceuticals files for $100M mixed securities shelf
|
May 17 |
Phio Pharmaceuticals Secures New Investor
|
May 16 |
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)
|
May 15 |
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
|
May 10 |
Phio Pharmaceuticals GAAP EPS of -$0.47
|
May 9 |
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
|